Labeling studies 712 INDEX

Finally, Shafran et al. [52] presented recently an open-label study on the efficacy and safety of rifaximin 600 mg/ day for 16 weeks in the treatment of mildly to moderately active CD. At the end of the study, 59% of patients were in remission (as defined by a Crohn s Disease Activity Index, CDAI, <150) with a significant reduction of the... 

Observational studies Safety data pooled from phase 11 and 111 clinical trials and an open-label study showed 1.3% of patients with serious infections, and 2.6% wilh malignancies. Four cardiovascular risk factors were retrospectively found to be predictors for the major adverse cardiovascular events seen in 27 patients during briakinumab treatment history of cardiovascular disease diabetes body mass index 0 baseline blood pressure systolic >140 and diastolic >90. Overall, the pooled briakinumab safety data indicated increased rates of infections, malignancies and major adverse cardiovascular events [123 ]. 

The results summarized above were obtained by using fluorescence based assays employing phospholipid vesicles and fluorescent labeled lipopeptides. Recently, surface plasmon resonance (SPR) was developed as new a technique for the study of membrane association of lipidated peptides. Thus, artificial membranes on the surface of biosensors offered new tools for the study of lipopeptides. In SPR (surface plasmon resonance) systemsI713bl changes of the refractive index (RI) in the proximity of the sensor layer are monitored. In a commercial BIAcore system1341 the resonance signal is proportional to the mass of macromolecules bound to the membrane and allows analysis with a time resolution of seconds. Vesicles of defined size distribution were prepared from mixtures of lipids and biotinylated lipopeptides by extruder technique and fused with a alkane thiol surface of a hydrophobic SPR sensor. 

P-450 content was induced in mice given 600 but not 300 mg/kg 1,4-dichlorobenzene for treatments of 4 and 13 weeks. Microsomal 7-pentoxyresorufm 0-depentylase activity was significantly induced in mouse liver microsomes at doses of 300 and 600 mg/kg 1,4-dichlorobenzene. Western immunoblotting studies demonstrated that 1,4-dichlorobenzene induced CYP2B isoenzyme(s) in mouse liver microsomes at 300 and 600 mg/kg 1,4-dichlorobenzene. Hepatocyte labeling index values were significantly increased in mice given 300 and 600 mg/kg 1,4-dichlorobenzene for 4 weeks (420% and 395% of controls, respectively) (Lake et al. 1997). 

In short-term renal toxicity studies in rats gavage administration of 1,1,2,2-tetra-chloroethane caused renal toxicity as evidenced by an increased renal tubule cell labeling index, indicating replicative DNA synthesis. In 2-year studies 1,1,2,2-tetrachloroethane administered by gavage produced an increased incidence of hepatocellular carcinomas in mice but not in rats. In one epidemiological study of exposed army workers there was a slight increase in deaths due to genital cancer and leukemia. Exposure levels were not available,... 

Andon (2003) compared five different CCM formulations covering a threefold range of Ca citrate malate molar ratios from 154 previous studies in humans. Intrinsically labeled tablets or juices comprising 250 mg Ca as CCM were tested in adolescents and groups of women 20 to 30-years and 40 to 77-years old. A comparison of mean values for age groups, molar ratios, and vehicles revealed no differences. Comparison with reported values in the literature, after adjustment to equalize Ca doses and indexing versus a standard (i.e., milk = 100), revealed Ca absorption from CCM consistently exceeded absorption from other sources including milk, various dairy products, fortified foods, and Ca supplements. 

Draft guidance for industry drug interaction studies-study design, data analysis, and implications for dosing and labeling http //www.fda.gov/cder/ guidance/index.htm (to be published in 2006). 

For in vivo incorporation of BrdU in experimental animals, inject 10-100 mg/kg of BrdU in 0.9% saline by the ip route. A concentration of 10 mg/mL is routinely used. The animal is sacrificed after 1 h for labeling index studies or at 1-2 hourly time intervals for cell cycle progression studies In vivo incorporation of BrdU into humans at Mount Vernon Hospital involves iv injection of 200 mg of BrdU in 20 mL of normal saline as a single bolus over 3-5 min... 

CONTENTS Preface, C. Allen Bush. Thermodynamic Solvent Isotope Effects and Molecular Hydrophobicity, Terrence G. Oas and Eric J. Toone. Membrane Interactions of Hemolytic and Antibacterial Peptides, Karl Lohner and Richard M. Epand. Spin-Labeled Metabolite Analogs as Probes of Enzyme Structure, Chakravarthy Narasimhan and Henry M. Miziorko. Current Perspectives on the Mechanism of Catalysis by the Enzyme Enolase, John M. Brewer and Lukasz Leb-ioda. Protein-DNA Interactions The Papillomavirus E2 Proteins as a Model System, Rashmi S. Hedge. NMR-Based Structure Determination for Unlabeled RNA and DNA, Philip N. Borer, Lucia Pappalardo, Deborah J. Kenwood, and Istvan Pelczer. Evolution of Mononuclear to Binuclear CuA An EPR Study, William E. Antholine. Index. 

Dardes, R. D. C. M., Horiguchi, J., and Jordan, V. C. 2000. A pilot study of the effects of short term tamoxifen therapy on Ki-67 labeling index in women with primary breast cancer, hit. J. Oncol. 7(5 25-30. 

Thompson et al. (2005) reported that tumor cell proliferation and c-erbB2 expression decreased by 34% and 71%, respectively, whereas cell apoptosis increased (31%) in menopausal women fed a diet containing 25 g of flaxseed. Changes in c-erbB2 score and apoptosis index were correlated with total flaxseed intake whereas cell proliferation, as measured by Ki-67 labeling index, was not. A main conclusion from these studies was that the lignans and, to a lesser extent, ALA were responsible for the anticarcinogenic activity. 

---